Nutriband (NTRBW) reports 2025 option and warrant exercise activity

Rhea-AI Filing Summary

Nutriband Inc. reported recent exercises of its outstanding stock options and warrants for the period from February 1 through July 31, 2025. Holders exercised stock options covering 20,055 shares of common stock for a total exercise price of $44,206.

During the same period, holders of the company’s publicly traded warrants (trading under symbol NTRBW) exercised warrants to purchase 47,076 shares of common stock for a total purchase price of $302,699. In addition, private investors exercised warrants to purchase 778,041 shares of common stock, generating a total exercise price of $5,002,804.

8-K Event Classification

2 items: 7.01, 9.01

2 items

Item 7.01 Regulation FD Disclosure Disclosure

Material non-public information disclosed under Regulation Fair Disclosure, often investor presentations or guidance.

Item 9.01 Financial Statements and Exhibits Exhibits

Financial statements, pro forma financial information, and exhibit attachments filed with this report.

Understanding 8-K Material Events →

false 0001676047 0001676047 2025-02-01 2025-02-01 0001676047 us-gaap:CommonStockMember 2025-02-01 2025-02-01 0001676047 NTRB:WarrantsMember 2025-02-01 2025-02-01 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549 

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of

the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): February 1, 2025

Nutriband Inc.

Nevada		000-40854		81-1118176
(State or Other Jurisdiction of Incorporation)		(Commission File Number)		(I.R.S. Employer Identification No.)

121 S. Orange Ave. Suite 1500 Orlando, Florida		32801
(Address of Principal Executive Offices)		(Zip Code)

(407) 377-6695

Registrant’s Telephone Number, Including Area Code

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). 

Emerging growth company ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐

Securities registered pursuant to Section 12(b) of the Act:

Title of each class		Trading Symbol(s)		Name of each exchange on which registered
Common Stock		NTRB		The Nasdaq Stock Market LLC
Warrants		NTRBW		The Nasdaq Stock Market LLC

Item 7.01. Regulation FD Disclosure.

Recent Exercises of Outstanding Company Options and Warrants

The following numbers of outstanding options and warrants of the Company have been exercised in the period February 1 through July 31, 2025: stock options covering 20,055 shares of common stock for a total exercise price of $44,206; public warrants (NTRBW) to purchase 47,076 shares of common stock for a total purchase price of $302,699; and warrants to purchase 778,041 shares of common stock exercised by private investors, for a total exercise price of $5,002,804.

Item 9.01 Financial Statements and Exhibits

(d) Exhibits

The following exhibits are being filed with this Current Report on Form 8-K:

104 Cover Page Interactive Data File (embedded within the Inline XBRL document)

1

SIGNATURES

PURSUANT TO THE REQUIREMENTS OF THE SECURITIES EXCHANGE ACT OF 1934, THE REGISTRANT HAS DULY CAUSED THIS REPORT TO BE SIGNED ON ITS BEHALF BY THE UNDERSIGNED THEREUNTO DULY AUTHORIZED.

	NUTRIBAND, INC.
Date:  September 3, 2025	By:	/s/ Serguei Melnik
		Serguei Melnik
		President

2

FAQ

What did Nutriband Inc. (NTRBW) disclose in this 8-K filing?

Nutriband Inc. disclosed the number of stock options and warrants that were exercised between February 1 and July 31, 2025, along with the related total exercise prices.

How many Nutriband stock options were exercised and for what amount?

Stock options covering 20,055 shares of Nutriband common stock were exercised for a total exercise price of $44,206 in the period disclosed.

How many public warrants (NTRBW) were exercised during the reported period?

Holders exercised public warrants (NTRBW) to purchase 47,076 shares of Nutriband common stock for a total purchase price of $302,699.

What was disclosed about private investor warrant exercises for Nutriband?

Private investors exercised warrants to purchase 778,041 shares of Nutriband common stock, with a total exercise price of $5,002,804 for the reported period.

Over what time frame did these Nutriband option and warrant exercises occur?

The disclosed exercises of Nutriband stock options and warrants occurred over the period from February 1 through July 31, 2025.

Does this Nutriband 8-K describe new securities being issued or a registration?

The disclosure describes exercises of existing outstanding options and warrants for Nutriband common stock over a defined period, rather than a new registration statement.